Champions Oncology
CSBR
CSBR
29 hedge funds and large institutions have $26.5M invested in Champions Oncology in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
43% less capital invested
Capital invested by funds: $46.8M → $26.5M (-$20.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
29
Holding in Top 10
1
Calls
$20K
Puts
$25K
Top Buyers
| 1 | +$1.23M | |
| 2 | +$21.6K | |
| 3 | +$21.5K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.92K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$690K | |
| 3 | -$105K | |
| 4 |
AC
Aristides Capital
Louisville,
Kentucky
|
-$68.2K |
| 5 |
Renaissance Technologies
New York
|
-$40.9K |